| Name | Title | Contact Details |
|---|
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.
Terumo Cardiovascular Systems' product line in perfusion circuits is not only one of the most comprehensive in the industry, but also offers an increasing array of products focused on helping surgical teams improve outcomes associated with
Comhar, Inc. is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Access Pro Medical is a supplier of burn and advanced wound care supplies to healthcare facilities.
Catholic Charities CYO is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Catholic Charities CYO is based in San Francisco, CA. You can find more information on Catholic Charities CYO at www.cccyo.org